Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, effectively reduces cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. It potentially enhances cognitive function through neurogenesis modulation and may have therapeutic effects on Alzheimer's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,140.00 | |
50 mg | 8-10 weeks | $ 1,490.00 | |
100 mg | 8-10 weeks | $ 2,360.00 |
Description | Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, effectively reduces cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. It potentially enhances cognitive function through neurogenesis modulation and may have therapeutic effects on Alzheimer's disease. |
Synonyms | Tunodafil |
Molecular Weight | 487.61 |
Formula | C24H33N5O4S |
CAS No. | 804518-63-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Yonkenafil 804518-63-6 Yonkenafil (free base) Tunodafil inhibitor inhibit